How should stool urgency and fecal incontinence be evaluated and managed?

Evaluation and Management of Stool Urgency and Fecal Incontinence

Start with a 2-week bowel diary to characterize stool consistency, frequency, and incontinence patterns, then proceed with anorectal manometry and digital rectal examination to identify sphincter dysfunction and guide treatment selection. 1, 2

Initial Assessment

Begin by documenting the specific pattern of symptoms using a structured bowel diary over 2 weeks 3, 2. This captures:

• Stool consistency (Bristol Stool Form Scale)
• Frequency of bowel movements
• Episodes of urgency vs. passive incontinence
• Volume and timing of leakage

Digital rectal examination is essential to assess:

• Resting anal sphincter tone
• Voluntary squeeze strength
• Presence of fecal impaction
• Structural abnormalities (rectocele, prolapse, fistulas) 4, 2

Check for incontinence-associated dermatitis (IAD), which indicates severity and requires specific skin care 2.

Diagnostic Testing

Anorectal manometry should be performed in patients not responding to initial conservative measures 1, 5. Key parameters include:

• Resting anal pressure (lower in urgency/incontinence patients: ~68 mmHg vs. 79 mmHg in controls)
• Squeeze pressure and fatigue rate index
• Rectal sensory thresholds (patients with urgency feel urge at lower volumes: ~81 ml vs. 107 ml)
• Presence of dyssynergic defecation pattern 5, 6

Endoanal ultrasound identifies sphincter defects—present in 24% (internal) and 22% (external) of patients with fecal incontinence 5, 2.

Risk Factor Identification

Diarrhea is by far the most important modifiable risk factor (odds ratio 53), followed by rectal urgency itself 4. Other significant factors include:

• Active inflammatory bowel disease
• Cholecystectomy (OR 4.2)
• Current smoking (OR 4.7)
• History of rectocele (OR 4.9)
• Obstetric anal sphincter injuries 4, 7

Notably, urinary urgency and urge incontinence co-occur in 40% of patients with fecal urgency, suggesting shared pathophysiology 6.

Treatment Algorithm

First-Line: Conservative Management

For patients with loose stools or diarrhea, start with fiber supplementation (methylcellulose 500 mg every 8 hours) and dietary modification 8. This simple intervention:

• Normalizes stool consistency in 66% of patients
• Reduces urgency episodes significantly
• Allows discharge without further treatment in 52% of cases
• Should be initiated at primary care level before specialist referral 8

Loperamide is appropriate for persistent diarrhea-associated urgency after fiber optimization 7.

Second-Line: Biofeedback Therapy

Biofeedback therapy is the treatment of choice for refractory fecal incontinence and defecatory disorders 4, 1. It achieves:

• 70-80% improvement in dyssynergic defecation
• 76% adequate relief in refractory fecal incontinence 1

Best candidates have:

• Dyssynergic defecation pattern on manometry plus abnormal balloon expulsion test
• Lower baseline rectal sensory thresholds
• Absence of severe depression
• Rectal urgency as a primary symptom 1

Rectal sensorimotor coordination training specifically improves rectal urgency 1. Treatment should be performed by trained pelvic floor physical therapists or specialized nurses under appropriate supervision.

Third-Line: Minimally Invasive Procedures

When conservative measures and biofeedback fail:

Sacral nerve stimulation is the preferred minimally invasive option for severe fecal incontinence with sphincter damage 4. However, sacral nerve stimulation should NOT be used for defecatory disorders based on limited evidence 4.

Perianal bulking injections may be considered before more invasive surgery 4.

Fourth-Line: Surgical Interventions

Sphincteroplasty is appropriate for patients with:

• Documented sphincter damage on ultrasound
• Failed conservative therapy and biofeedback
• Unavailable or unsuccessful sacral nerve stimulation 4

Major anatomic defects (rectovaginal fistula, full-thickness rectal prolapse, fistula-in-ano) require surgical correction 4.

Colostomy should be considered when all other treatments have failed or are contraindicated 4. This can significantly improve quality of life in severe refractory cases 2.

Special Populations

Inflammatory Bowel Disease

Control of active inflammation is paramount—clinical disease activity independently predicts fecal incontinence severity (P=0.0325) 5. Fecal urgency persists even during inflammatory quiescence in many patients, requiring symptom-directed management 9, 7.

Postpartum Patients

When obstetric anal sphincter injury is present, refer early to a specialized center for repair 2. Without identified injury, observation for one year is reasonable before intervention. For subsequent pregnancies after OASIS, evaluate sphincter function and integrity before deciding on delivery mode 2.

Elderly and Frail Patients

Patients >74 years have more frequent solid fecal incontinence but paradoxically report better quality of life scores, likely due to different expectations 3. They have lower anorectal pressures and may benefit from barrier devices or containment strategies 2.

Common Pitfalls

• Don't assume all urgency is diarrhea-related: 47% of patients with urgency have constipation patterns 9
• Don't overlook stool consistency: Simple fiber supplementation resolves symptoms in half of selected patients 8
• Don't perform STARR procedures routinely for structural abnormalities in defecatory disorders—they are not recommended 4
• Don't use anterograde colonic enemas for long-term management of defecatory disorders—they are ineffective 4
• Don't forget to assess for urinary symptoms: 40% have concurrent urge urinary incontinence requiring coordinated management 6